Related Experiment Video
Updated: May 25, 2026
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
A Phenotype-Driven Dimension Reduction (PhDDR) approach to integrated genomic association analyses
1Department of Biostatistics, St Jude Children’s Research Hospital, Memphis, TN 38105, USA.
Summary
High-dimensional genomic data presents challenges for integrated analysis. We introduce Phenotype-Driven Dimension Reduction (PhDDR) for gene co-expression analysis, improving efficiency in childhood leukemia treatment response studies.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Integrated genomic analysis faces ultra-high dimensionality challenges with genome-wide factors.
- Screening all potential genomic factor relationships is computationally intractable (NP-hard).
- Effective dimension reduction is crucial for practical genomic data analysis.
Purpose of the Study:
- To develop a novel approach for dimension reduction in integrated genomic analysis.
- To apply this method to gene co-expression analysis, specifically for treatment response.
- To extend the approach for integrating diverse genetic factors.
Main Methods:
- Developed the Phenotype-Driven Dimension Reduction (PhDDR) approach.
- Applied PhDDR to analyze gene co-expressions.
- Explored extensions for integrating additional genetic factors.
Main Results:
- Demonstrated the utility of PhDDR in handling ultra-high dimensional genomic data.
- Successfully applied the approach to gene co-expression analysis in childhood leukemia.
- Provided a framework for more efficient integrated genomic analyses.
Conclusions:
- Phenotype-Driven Dimension Reduction (PhDDR) offers an effective solution for high-dimensional genomic data.
- The method facilitates gene co-expression analysis and can be extended to other genetic factors.
- PhDDR aids in understanding complex biological systems, such as treatment response in childhood leukemia.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...